Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Open access
2,748
Views
29
CrossRef citations to date
0
Altmetric
Research Article
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
Najla AltwaijryStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; View further author information
, Sukrut SomaniStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; View further author information
, John A. ParkinsonDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK; View further author information
, Rothwelle J. TateStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; View further author information
, Patricia KeatingDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK; View further author information
, Monika WarzechaStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; View further author information
, Graeme R. MackenzieStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; View further author information
, Hing Y. LeungCancer Research UK Beatson Institute, Glasgow, UKView further author information
& Christine DufèsStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; Correspondence[email protected]
View further author information
show allView further author information
Pages 679-689
|
Received 13 Dec 2017, Accepted 11 Feb 2018, Published online: 01 Mar 2018
Related Research Data
Lactoferrin and cancer in different cancer models
Source:
Frontiers in Bioscience
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
Source:
Taylor & Francis
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
Source:
Taylor & Francis
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
Source:
Taylor & Francis
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Source:
Annual Reviews
Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
Source:
Elsevier BV
Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells
Source:
Springer Nature
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
Source:
Springer Nature
Pharmaceutical Perspectives of Nonviral Gene Therapy
Source:
Elsevier
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer
Source:
Springer Nature
Globocan 2012
Source:
Wiley
Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex
Source:
Elsevier BV
Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes
Source:
Elsevier BV
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Source:
Elsevier BV
Validation of the Transferrin Receptor for Drug Targeting to Brain Capillary Endothelial Cells In Vitro
Source:
Informa UK Limited
Endocytosis and Signal Transduction: Basic Science Update
Source:
SAGE Publications
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
Source:
Springer Nature
Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years.
Source:
Springer Science and Business Media LLC
Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas
Source:
Future Medicine Ltd
Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice
Source:
Springer Nature
Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex
Source:
Elsevier BV
Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature
Source:
Springer Nature
Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier
Source:
Elsevier BV
Chapter 1 – Introduction to Bioconjugation
Source:
Elsevier
Tumor necrosis factor, cancer and anticancer therapy.
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.